GBP-213 in Patients With Autosomal Dominant Polycystic Kidney Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of GBP-213 in patients with autosomal dominant polycystic kidney disease (ADPKD).
Epistemonikos ID: 35d6fe3844b3116608a980b9a9660e3add3ef587
First added on: Oct 24, 2026